Vitamin B supplements may protect kidney function in children and adolescents with type-1 diabetes, suggests a study. These findings indicate that simple supplementation of vitamin B complex may protect against the development and progression of kidney disease in children with diabetes, which could promote improved health and quality of life in adulthood.
Type-1 diabetes is a life-long disease in which the body does not make enough insulin to regulate blood glucose levels. The condition is usually diagnosed in childhood and can lead to serious and debilitating complications, including diabetic kidney disease.
This common complication develops over many years, but has no symptoms in the early stages, so if undetected can necessitate long-term, intensive or expensive treatments, and lead to earlier death in adulthood. Vitamin B deficiency is associated with an increased risk of kidney damage and is often observed in children and adults with type-1 diabetes.
However, whether supplements can improve blood glucose regulation or kidney function in vitamin B deficient type-1 diabetic children had not yet been fully investigated.
Professor Elbarbary of Ain Shams University in Cairo said, “After 12 weeks of vitamin B complex supplementation in children and adolescents with diabetic kidney disease, we detected lower levels of markers that indicate poor kidney function, suggesting that it had a protective effect and could slow progression of the disease.”
Elbarbary added, “Although the best strategy for treating diabetic kidney disease is prevention, for example, through better blood glucose control and maintenance of healthy blood pressure, a normal lipid profile and a healthy body weight, the long-term duration of diabetes still increases the risk of developing kidney disease. So, these findings suggest vitamin B supplementation, in addition to traditional angiotensin converting enzyme inhibitor therapy may be a simple, safe and cost-effective strategy for early protection of kidney function, which may improve the long-term quality of life for type-1 diabetes patients.”
The research was presented at the 57th Annual European Society for Paediatric Endocrinology Meeting.

more recommended stories
BorderPlus Commits ₹10 Crore in Scholarships Over the Next 2 YearsMUMBAI/KOCHI:This International Nurses Day, BorderPlus, a.
Global Health Experts Appointed to Judge Aster Guardians Global Nursing Award 2025KOCHI:Aster DM Healthcare, one of the.
A Doctor’s Touch, Twice BlessedKOCHI:Dr. Mathew Jacob was all smiles.
Aster Medcity Hosts Scoliosis Diagnosis CampKOCHI:Aster Spine Centre at Aster Medcity.
National Conclave on CAR-T Cell Therapy Held in KochiKOCHI:Dr. Divya S. Iyer, Managing Director.
Aster Medcity Observes World Autism Awareness Day 2025KOCHI:Aster Medcity celebrated World Autism Awareness.
Revolutionary Cardiac Milestone Funded by Manipal Foundation CSRKOLKATA:In a rarest of rare case.
Aster Medcity Organizes ‘Traumax-2025’ to Promote Care of Trauma VictimKOCHI:Aster Medcity organized TRAUMAX 2025, a.
53% Surveyed Experience Sleep-related DisordersMUMBAI:Ahead of World Sleep Day, YouGov.
Cosmopolitan Hospital Conducts Patient Safety Awareness Week Walkathon 2025THIRUVANANTHAPURAM:Cosmopolitan Hospital organized the Patient Safety.